Served as copy lead for multiple deliverables supporting the launch of YEZTUGO. This drug development is a widely publicized, groundbreaking pre-exposure prophylaxis (PrEP) medication that prevents HIV transmission in adults, representing the most significant advancement toward HIV prevention globally.

Pre-launch responsibilities included ensuring content clarity, consistency across deliverables, and reference-based accuracy that met FDA approval standards.